Non-Canonical NF-κB Activation and Abnormal B Cell Accumulation in Mice Expressing Ubiquitin Protein Ligase-Inactive c-IAP2

被引:41
作者
Conze, Dietrich B. [1 ]
Zhao, Yongge [1 ]
Ashwell, Jonathan D. [1 ]
机构
[1] NCI, Lab Immune Cell Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
NECROSIS-FACTOR-ALPHA; LYMPHOID-TISSUE LYMPHOMAS; MALT LYMPHOMA; TNF-ALPHA; DEPENDENT APOPTOSIS; SIGNALING PATHWAY; MULTIPLE-MYELOMA; NF-KAPPA-B2; P100; SURVIVAL SIGNALS; TRAF2;
D O I
10.1371/journal.pbio.1000518
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chromosomal translocations between loci encoding MALT1 and c-IAP2 are common in MALT lymphomas. The resulting fusion proteins lack the c-IAP2 RING domain, the region responsible for its ubiquitin protein ligase (E3) activity. Ectopic expression of the fusion protein activates the canonical NF-kappa B signaling cascade, but how it does so is controversial and how it promotes MALT lymphoma is unknown. Considering recent reports implicating c-IAP1 and c-IAP2 E3 activity in repression of non-canonical NF-kappa B signaling, we asked if the c-IAP2/ MALT fusion protein can initiate non-canonical NF-kappa B activation. Here we show that in addition to canonical activation, the fusion protein stabilizes NIK and activates non-canonical NF-kappa B. Canonical but not non-canonical activation depended on MALT1 paracaspase activity, and expression of E3-inactive c-IAP2 activated non-canonical NF-kappa B. Mice in which endogenous c-IAP2 was replaced with an E3-inactive mutant accumulated abnormal B cells with elevated non-canonical NF-kappa B and had increased numbers of B cells with a marginal zone phenotype, gut-associated lymphoid hyperplasia, and other features of MALT lymphoma. Thus, the c-IAP2/MALT1 fusion protein activates NF-kappa B by two distinct mechanisms, and loss of c-IAP2 E3 activity in vivo is sufficient to induce abnormalities common to MALT lymphoma.
引用
收藏
页数:13
相关论文
共 66 条
[41]   A novel TRAF6 binding site in MALT1 defines distinct mechanisms of NF-κB activation by API2•MALT1 fusions [J].
Noels, Heidi ;
van Loo, Geert ;
Hagens, Sofie ;
Broeckx, Vicky ;
Beyaert, Rudi ;
Marynen, Peter ;
Baens, Mathijs .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (14) :10180-10189
[42]   Translocations t(11;18)(q21;q21) and t(14;18)(q32;q21) are the main chromosomal abnormalities involving MLT/MALT1 in MALT lymphomas [J].
Penas, EMM ;
Hinz, K ;
Röser, K ;
Copie-Bergman, C ;
Wlodarska, I ;
Marynen, P ;
Hagemeijer, A ;
Gaulard, P ;
Löning, T ;
Hossfeld, DK ;
Dierlamm, J .
LEUKEMIA, 2003, 17 (11) :2225-2229
[43]   The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral-inhibitor of apoptosis proteins [J].
Rothe, M ;
Pan, MG ;
Henzel, WJ ;
Ayres, TM ;
Goeddel, DV .
CELL, 1995, 83 (07) :1243-1252
[44]   NIK overexpression amplifies, whereas ablation of its TRAF3-binding domain replaces BAFF:BAFF-R-mediated survival signals in B cells [J].
Sasaki, Yoshiteru ;
Calado, Dinis P. ;
Derudder, Emmanuel ;
Zhang, Baochun ;
Shimizu, Yuri ;
Mackay, Fabienne ;
Nishikawa, Shin-ichi ;
Rajewsky, Klaus ;
Schmidt-Supprian, Marc .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (31) :10883-10888
[45]   Activation by IKKα of a second, evolutionary conserved, NF-κB signaling pathway [J].
Senftleben, U ;
Cao, YX ;
Xiao, GT ;
Greten, FR ;
Krähn, G ;
Bonizzi, G ;
Chen, Y ;
Hu, YL ;
Fong, A ;
Sun, SC ;
Karin, M .
SCIENCE, 2001, 293 (5534) :1495-1499
[46]  
SPENCER J, 1985, CLIN EXP IMMUNOL, V62, P607
[47]   IAPs: What's in a name? [J].
Srinivasula, Srinivasa M. ;
Ashwell, Jonathan D. .
MOLECULAR CELL, 2008, 30 (02) :123-135
[48]   Activation of NF-κB and inhibition of p53-mediated apoptosis by API2/mucosa-associated lymphoid tissue 1 fusions promote oncogenesis [J].
Stoffel, A ;
Chaurushiya, M ;
Singh, B ;
Levine, AJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (24) :9079-9084
[49]   A role for NF-κB essential modifier/IκB kinase-γ (NEMO/IKKγ) ubiquitination in the activation of the IκB kinase complex by tumor necrosis factor-α [J].
Tang, ED ;
Wang, CY ;
Xiong, Y ;
Guan, KL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (39) :37297-37305
[50]  
Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(00)00094-0